Clinical Trial Update: PrProfile: A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ION717 [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for ION717 in prion disease, currently recruiting in Phase 1/2 to assess safety, tolerability, pharmacokinetics and pharmacodynamics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prion Disease

Drugs mentioned

• ION717 (ION717)

Snippet

Sponsor: Ionis Pharmaceuticals, Inc. | Conditions: Prion Disease | Phase 1, Phase 2 | Status: RECRUITING